Indian-American oncologist and Pulitzer prize-winning author Dr Siddhartha Mukherjee has joined hands with Biocon Chairperson Kiran Mazumdar Shaw to bring innovative Chimeric Antigen Receptor (CAR) T-cell therapy to cancer patients in India. In a free-wheeling interview with CNBC-TV18, Mukherjee talks about the cutting edge treatment and its implications on cancer care in the country.